JP2016526535A5 - - Google Patents

Download PDF

Info

Publication number
JP2016526535A5
JP2016526535A5 JP2016519625A JP2016519625A JP2016526535A5 JP 2016526535 A5 JP2016526535 A5 JP 2016526535A5 JP 2016519625 A JP2016519625 A JP 2016519625A JP 2016519625 A JP2016519625 A JP 2016519625A JP 2016526535 A5 JP2016526535 A5 JP 2016526535A5
Authority
JP
Japan
Prior art keywords
difluoro
substituted
ethynyl
tetrazol
difluorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016519625A
Other languages
English (en)
Japanese (ja)
Other versions
JP6386035B2 (ja
JP2016526535A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/041984 external-priority patent/WO2014201161A1/en
Publication of JP2016526535A publication Critical patent/JP2016526535A/ja
Publication of JP2016526535A5 publication Critical patent/JP2016526535A5/ja
Application granted granted Critical
Publication of JP6386035B2 publication Critical patent/JP6386035B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016519625A 2013-06-12 2014-06-11 金属酵素阻害剤化合物 Expired - Fee Related JP6386035B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361834324P 2013-06-12 2013-06-12
US61/834,324 2013-06-12
PCT/US2014/041984 WO2014201161A1 (en) 2013-06-12 2014-06-11 Metalloenzyme inhibitor compounds

Publications (3)

Publication Number Publication Date
JP2016526535A JP2016526535A (ja) 2016-09-05
JP2016526535A5 true JP2016526535A5 (cg-RX-API-DMAC7.html) 2017-06-22
JP6386035B2 JP6386035B2 (ja) 2018-09-05

Family

ID=52022749

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016519625A Expired - Fee Related JP6386035B2 (ja) 2013-06-12 2014-06-11 金属酵素阻害剤化合物

Country Status (9)

Country Link
US (1) US9688671B2 (cg-RX-API-DMAC7.html)
EP (1) EP3008051A4 (cg-RX-API-DMAC7.html)
JP (1) JP6386035B2 (cg-RX-API-DMAC7.html)
KR (1) KR20160018811A (cg-RX-API-DMAC7.html)
CN (1) CN105431418B (cg-RX-API-DMAC7.html)
AU (1) AU2014278172B2 (cg-RX-API-DMAC7.html)
CA (1) CA2915054A1 (cg-RX-API-DMAC7.html)
EA (1) EA201690007A1 (cg-RX-API-DMAC7.html)
WO (1) WO2014201161A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102070345B1 (ko) 2011-12-11 2020-01-28 마이코비아 파마슈티컬즈, 인코포레이티드 금속효소 억제제 화합물
CN104136427B (zh) * 2012-01-20 2017-03-01 威尔金制药有限公司 金属酶抑制剂化合物
US10017494B2 (en) 2014-03-19 2018-07-10 Mycovia Pharmaceuticals, Inc. Antifungal compound process
AU2015231275B2 (en) 2014-03-19 2019-03-07 Mycovia Pharmaceuticals, Inc. Antifungal compound process
JP2017507991A (ja) 2014-03-19 2017-03-23 ヴィアメット ファーマスーティカルズ,インコーポレイテッド 抗真菌化合物の調製方法
EA201691648A1 (ru) 2014-03-19 2017-01-30 Ваймет Фармасьютикалс, Инк. Способ получения противогрибковых соединений
AU2015231216B2 (en) 2014-03-19 2019-04-04 Mycovia Pharmaceuticals, Inc. Antifungal compound process
EP3119756B9 (en) 2014-03-19 2021-08-25 Dow AgroSciences LLC 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1h-tetrazol-1-yl)propan-2-ols and processes for their preparation
BR112016021257B1 (pt) 2014-03-19 2021-03-02 Viamet Pharmaceuticals (NC), Inc. 2-(2,4- difluorofenil-1,1-diflúor-1-(5-substituído-piridin-2-il)-3- (1h-tetrazol-1-il)propan-2-óis e processos para preparação e uso dos mesmos
CA2942972A1 (en) 2014-03-19 2015-09-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antifungal compound process
KR102151082B1 (ko) 2014-03-19 2020-09-03 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 시크리터리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시스 항진균 화합물 제조방법
JP6639497B2 (ja) 2014-11-10 2020-02-05 ジェネンテック, インコーポレイテッド ブロモドメインインヒビターおよびその使用
MA40940A (fr) 2014-11-10 2017-09-19 Constellation Pharmaceuticals Inc Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
MA40943A (fr) 2014-11-10 2017-09-19 Constellation Pharmaceuticals Inc Pyrrolopyridines substituées utilisées en tant qu'inhibiteurs de bromodomaines
CN107531692B (zh) * 2015-01-29 2020-12-25 基因泰克公司 治疗化合物及其用途
KR102798709B1 (ko) * 2015-09-18 2025-04-23 마이코비아 파마슈티컬즈, 인코포레이티드 항진균 화합물 제조 방법
EP3397629B1 (en) * 2015-12-30 2023-04-19 NQP 1598, Ltd. Metalloenzyme inhibitor compounds
SG11202008113RA (en) 2018-03-05 2020-09-29 Arcus Biosciences Inc Arginase inhibitors
JP7503561B2 (ja) * 2018-10-29 2024-06-20 ファーハイ ユーエス インコーポレイテッド 新規ジペプチド化合物及びその使用方法
TWI828800B (zh) 2018-11-16 2024-01-11 美商阿克思生物科學有限公司 Arg1及/或arg2之抑制劑
ES3034708T3 (en) * 2019-06-27 2025-08-21 Univ Nanyang Tech 1,1'-[1,3-(5-methoxy)phenylenebis(methylene)]bis[4,5-diphenyl-1h-imidazole] and similar compounds for the treatment of malaria
CN110885323A (zh) * 2019-12-02 2020-03-17 中国人民解放军第二军医大学 一种三氮唑醇类衍生物、其制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080062876A (ko) 2006-12-29 2008-07-03 주식회사 대웅제약 신규한 항진균성 트리아졸 유도체
JP5266430B2 (ja) * 2010-04-24 2013-08-21 ヴィアメット ファーマスーティカルズ,インコーポレイテッド 金属酵素阻害化合物
EA201490038A1 (ru) 2011-06-19 2014-04-30 Вайамет Фармасьютикалс, Инк. Соединения, ингибирующие металлоферменты
AU2012273103B2 (en) 2011-06-19 2017-04-20 Viamet Pharmaceuticals (NC), Inc. Metalloenzyme inhibitor compounds
AU2012273004B2 (en) * 2011-06-23 2017-04-13 Mycovia Pharmaceuticals, Inc. Metalloenzyme inhibitor compounds
KR102070345B1 (ko) 2011-12-11 2020-01-28 마이코비아 파마슈티컬즈, 인코포레이티드 금속효소 억제제 화합물

Similar Documents

Publication Publication Date Title
JP2016526535A5 (cg-RX-API-DMAC7.html)
JP6386035B2 (ja) 金属酵素阻害剤化合物
AU2011242562B2 (en) Metalloenzyme inhibitor compounds
US11247981B2 (en) Metalloenzyme inhibitor compounds
US10919874B2 (en) Metalloenzyme inhibitor compounds